Beyond Insulin: Semaglutide May Be First Breakthrough Drug for Type 1 Diabetes in 100 Years
For 100 years, insulin has been the primary treatment for type 1 diabetes (T1D) and despite being a lifesaver for millions, it is far from perfect. New clinical trials indicate that semaglutide, the active ingredient in Ozempic and Wegovy, may be the first significant add-on therapy for T1D since the introduction of insulin in 1921. ...
